| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| HCAHCA Healthcare, Inc. | 110.4B | 483.80 | 21.99 | 8.67% | 8.57% | 7.13% | 5.11% | 81.51 |
| UHSUniversal Health Services, Inc. | 11.28B | 204.19 | 12.14 | 10.82% | 8.09% | 18.85% | 9.96% | 0.73 |
| THCTenet Healthcare Corporation | 17.69B | 201.32 | 6.16 | 0.57% | 6.49% | 15.56% | 6.31% | 1.68 |
| ARDTArdent Health Partners, LLC | 1.27B | 8.90 | 5.63 | 10.29% | 3.24% | 12.57% | 10.01% | 1.50 |
| AUNAAuna S.A. | 138.14M | 4.59 | 2.82 | 14.47% | 4.33% | 10.05% | 100% | 2.32 |
| CYHCommunity Health Systems, Inc. | 462.66M | 3.34 | -0.86 | 1.15% | 2.6% | 25.94% |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 2.11B | 3B | 4.16B | 5.13B | 5.41B | 5.97B |
| Revenue Growth % | - | 0.43% | 0.39% | 0.23% | 0.05% | 0.1% |
| Cost of Goods Sold | 0 | 0 | 0 | 955.17M | 140.84M | 1.03B |
| COGS % of Revenue | - | - | - | 0.19% | 0.03% | 0.17% |
| Gross Profit | 2.11B | 3B | 4.16B | 4.17B | 5.27B | 4.93B |
| Gross Margin % | 1% | 1% | 1% | 0.81% | 0.97% | 0.83% |
| Gross Profit Growth % | - | 0.43% | 0.39% | 0% | 0.26% | -0.06% |
| Operating Expenses | 2.11B | 2.77B | 4.08B | 3.96B | 5.04B | 4.53B |
| OpEx % of Revenue | 1% | 0.92% | 0.98% | 0.77% | 0.93% | 0.76% |
| Selling, General & Admin | 1.95B | 1.17B | 2.68B | 3.37B | 3.62B | 3.88B |
| SG&A % of Revenue | 0.93% | 0.39% | 0.64% | 0.66% | 0.67% | 0.65% |
| Research & Development | 0 | 19.9M | 15.7M | 0 | 0 | 0 |
| R&D % of Revenue | - | 0.01% | 0% | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 585.81M | 1.42B | 642.51M |
| Operating Income | 84.75M | 121.77M | 149.76M | 217.03M | 229.5M | 405.76M |
| Operating Margin % | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.07% |
| Operating Income Growth % | - | 0.44% | 0.23% | 0.45% | 0.06% | 0.77% |
| EBITDA | 156.27M | 231.3M | 292.95M | 355.2M | 370.35M | 552.05M |
| EBITDA Margin % | 0.07% | 0.08% | 0.07% | 0.07% | 0.07% | 0.09% |
| EBITDA Growth % | - | 0.48% | 0.27% | 0.21% | 0.04% | 0.49% |
| D&A (Non-Cash Add-back) | 71.51M | 109.53M | 143.19M | 138.17M | 140.84M | 146.29M |
| EBIT | 71.32M | 121.38M | 101.68M | 393.53M | 209.15M | 428.64M |
| Net Interest Income | -26.95M | -70.74M | -108.59M | -82.05M | -65.42M | -65.58M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 26.95M | 70.74M | 108.59M | 82.05M | 65.42M | 65.58M |
| Other Income/Expense | -40.38M | -71.13M | -264.37M | 94.45M | -77.89M | -42.7M |
| Pretax Income | 44.37M | 50.64M | -114.62M | 311.48M | 151.61M | 363.06M |
| Pretax Margin % | 0.02% | 0.02% | -0.03% | 0.06% | 0.03% | 0.06% |
| Income Tax | 8.02M | 49.87M | -11.29M | 46.11M | 22.64M | 63.35M |
| Effective Tax Rate % | 0.33% | -0.7% | 1.25% | 0.61% | 0.33% | 0.58% |
| Net Income | 14.6M | -35.65M | -143.02M | 188.91M | 50.29M | 210.34M |
| Net Margin % | 0.01% | -0.01% | -0.03% | 0.04% | 0.01% | 0.04% |
| Net Income Growth % | - | -3.44% | -3.01% | 2.32% | -0.73% | 3.18% |
| Net Income (Continuing) | 36.35M | 774K | -103.33M | 265.37M | 128.98M | 299.71M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 129.47M | 382.55M | 380.19M | 411.26M | 411.42M | 390.98M |
| EPS (Diluted) | 0.10 | -0.25 | -1.01 | 1.32 | 0.35 | 1.58 |
| EPS Growth % | - | -3.5% | -3.04% | 2.31% | -0.73% | 3.51% |
| EPS (Basic) | 0.10 | -0.25 | -1.01 | 1.32 | 0.35 | 1.59 |
| Diluted Shares Outstanding | 140.96M | 140.96M | 140.96M | 143.26M | 143.26M | 132.75M |
| Basic Shares Outstanding | 140.96M | 140.96M | 140.96M | 143.26M | 143.26M | 132.44M |
| Dividend Payout Ratio | - | - | - | 0.93% | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 471.15M | 736.42M | 860.42M | 1.41B | 1.62B | 1.83B |
| Cash & Short-Term Investments | 92.61M | 71.96M | 59.66M | 456.12M | 437.58M | 556.78M |
| Cash Only | 92.61M | 71.96M | 59.66M | 456.12M | 437.58M | 556.78M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 261.04M | 453.85M | 529.12M | 611.96M | 785.76M | 743.03M |
| Days Sales Outstanding | 45.26 | 55.18 | 46.4 | 43.54 | 53.02 | 45.46 |
| Inventory | 47.09M | 84.16M | 84.81M | 107.15M | 105.48M | 115.09M |
| Days Inventory Outstanding | - | - | - | 40.95 | 273.37 | 40.66 |
| Other Current Assets | 31.08M | 66.82M | 100.57M | 165.05M | 211.99M | 304.09M |
| Total Non-Current Assets | 614.21M | 1.64B | 1.89B | 3.45B | 3.48B | 3.12B |
| Property, Plant & Equipment | 256.53M | 591.57M | 839.89M | 1.99B | 2.01B | 2.04B |
| Fixed Asset Turnover | 8.21x | 5.07x | 4.96x | 2.58x | 2.69x | 2.93x |
| Goodwill | 244.49M | 818.19M | 822.03M | 844.7M | 844.7M | 852.08M |
| Intangible Assets | 71.78M | 78.26M | 77.83M | 76.93M | 76.93M | 76.93M |
| Long-Term Investments | 0 | 0 | 0 | 29.4M | 17.8M | 11.46M |
| Other Non-Current Assets | 37.76M | 62.83M | 50.11M | 93.98M | 129.31M | 131.5M |
| Total Assets | 1.09B | 2.37B | 2.75B | 4.86B | 5.1B | 4.96B |
| Asset Turnover | 1.94x | 1.26x | 1.52x | 1.06x | 1.06x | 1.20x |
| Asset Growth % | - | 1.19% | 0.16% | 0.77% | 0.05% | -0.03% |
| Total Current Liabilities | 328.14M | 507.35M | 624.83M | 808.6M | 994.1M | 945.42M |
| Accounts Payable | 131.94M | 226.48M | 230.36M | 320.8M | 474.54M | 401.25M |
| Days Payables Outstanding | - | - | - | 122.59 | 1.23K | 141.76 |
| Short-Term Debt | 7.67M | 16.88M | 8.96M | 58.42M | 61.03M | 9.23M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 39.98M | 56.7M | 190.75M | 167.84M | 172.82M | 44.66M |
| Current Ratio | 1.44x | 1.45x | 1.38x | 1.74x | 1.63x | 1.94x |
| Quick Ratio | 1.29x | 1.29x | 1.24x | 1.61x | 1.52x | 1.82x |
| Cash Conversion Cycle | - | - | - | -38.1 | -903.42 | -55.64 |
| Total Non-Current Liabilities | 361.22M | 1.11B | 1.41B | 3B | 3.03B | 2.49B |
| Long-Term Debt | 232.7M | 935.81M | 1.25B | 1.15B | 1.15B | 1.07B |
| Capital Lease Obligations | 0 | 0 | 0 | 1.18B | 1.18B | 1.16B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 381.03M | 371.21M | 0 |
| Other Non-Current Liabilities | 128.51M | 171.09M | 157.7M | 290.01M | 319.55M | 261.75M |
| Total Liabilities | 689.36M | 1.61B | 2.03B | 3.81B | 4.02B | 3.43B |
| Total Debt | 240.37M | 952.69M | 1.26B | 2.39B | 2.4B | 2.28B |
| Net Debt | 147.76M | 880.73M | 1.2B | 1.93B | 1.96B | 1.73B |
| Debt / Equity | 0.61x | 1.25x | 1.77x | 2.27x | 2.21x | 1.50x |
| Debt / EBITDA | 1.54x | 4.12x | 4.30x | 6.72x | 6.47x | 4.13x |
| Net Debt / EBITDA | 0.95x | 3.81x | 4.10x | 5.44x | 5.29x | 3.13x |
| Interest Coverage | 3.15x | 1.72x | 1.38x | 2.65x | 3.51x | 6.19x |
| Total Equity | 396.01M | 760.28M | 711.84M | 1.05B | 1.08B | 1.52B |
| Equity Growth % | - | 0.92% | -0.06% | 0.48% | 0.03% | 0.41% |
| Book Value per Share | 2.81 | 5.39 | 5.05 | 7.33 | 7.55 | 11.47 |
| Total Shareholders' Equity | 266.54M | 377.72M | 331.64M | 639.05M | 670.9M | 1.13B |
| Common Stock | 255.03M | 401.86M | 504.69M | 510.97M | 496.88M | 1.43M |
| Retained Earnings | 11.51M | -24.14M | -167.16M | 101.55M | 155.45M | 365.8M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | -5.89M | 26.53M | 18.56M | 9.74M |
| Minority Interest | 129.47M | 382.55M | 380.19M | 411.26M | 411.42M | 390.98M |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 85.78M | 119.47M | 159.59M | -38.36M | 221.7M | 315.03M |
| Operating CF Margin % | 0.04% | 0.04% | 0.04% | -0.01% | 0.04% | 0.05% |
| Operating CF Growth % | - | 0.39% | 0.34% | -1.24% | 6.78% | 0.42% |
| Net Income | 14.6M | -35.65M | -143.02M | 265.37M | 128.98M | 299.71M |
| Depreciation & Amortization | 71.51M | 109.53M | 143.19M | 138.17M | 140.84M | 146.29M |
| Stock-Based Compensation | 0 | 0 | 0 | 611K | 904K | 17.98M |
| Deferred Taxes | -12.71M | 49.7M | -7.82M | 46.12M | 4M | 24.04M |
| Other Non-Cash Items | 43.08M | 45.83M | 152.7M | -478.89M | 3.29M | 8.76M |
| Working Capital Changes | -30.71M | -49.94M | 14.54M | -9.74M | -56.31M | -181.75M |
| Change in Receivables | -17.72M | -63.82M | -9.05M | -17.18M | -181.1M | 40M |
| Change in Inventory | 56K | -3.61M | -1.03M | 4.67M | 1.67M | -9.41M |
| Change in Payables | -9.28M | 41.3M | 37.15M | 14.42M | 136.82M | -103.86M |
| Cash from Investing | -64.83M | -966.93M | -482.14M | 46.58M | -137.98M | -220.46M |
| Capital Expenditures | -80.5M | -121.53M | -160.66M | -151.11M | -137.41M | -187.51M |
| CapEx % of Revenue | 0.04% | 0.04% | 0.04% | 0.03% | 0.03% | 0.03% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 18.17M | 12.16M | 28.35M | -8.69M | -575K | -1.71M |
| Cash from Financing | -25.89M | 826.81M | 353.22M | -270.33M | -102.26M | 24.64M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | -174.81M | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -20.22M | -35.64M | 1.47M | -79.11M | -95.24M | -79.24M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 3.62M | -2.06M | -1.07M | -189.47M | 84.29M | 127.52M |
| FCF Margin % | 0% | -0% | -0% | -0.04% | 0.02% | 0.02% |
| FCF Growth % | - | -1.57% | 0.48% | -175.91% | 1.44% | 0.51% |
| FCF per Share | 0.03 | -0.01 | -0.01 | -1.32 | 0.59 | 0.96 |
| FCF Conversion (FCF/Net Income) | 5.87x | -3.35x | -1.12x | -0.20x | 4.41x | 1.50x |
| Interest Paid | 26.01M | 64.63M | 86.54M | 90.85M | 81.61M | 74.98M |
| Taxes Paid | 23.62M | 2.37M | 5.55M | 55.82M | 19.43M | 41.6M |
| Metric | 2016 | 2017 | 2018 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 3.69% | -6.17% | -19.43% | 21.44% | 4.72% | 16.15% |
| Return on Invested Capital (ROIC) | 11.69% | 8.36% | 6.32% | 6.65% | 5.71% | 9.68% |
| Gross Margin | 100% | 100% | 100% | 81.38% | 97.4% | 82.68% |
| Net Margin | 0.69% | -1.19% | -3.44% | 3.68% | 0.93% | 3.53% |
| Debt / Equity | 0.61x | 1.25x | 1.77x | 2.27x | 2.21x | 1.50x |
| Interest Coverage | 3.15x | 1.72x | 1.38x | 2.65x | 3.51x | 6.19x |
| FCF Conversion | 5.87x | -3.35x | -1.12x | -0.20x | 4.41x | 1.50x |
| Revenue Growth | - | 42.6% | 38.63% | 23.25% | 5.45% | 10.29% |
| 2024 | |
|---|---|
| Reportable | 5.97B |
| Reportable Growth | - |
Ardent Health Partners, LLC (ARDT) has a price-to-earnings (P/E) ratio of 5.6x. This may indicate the stock is undervalued or faces growth challenges.
Ardent Health Partners, LLC (ARDT) reported $6.33B in revenue for fiscal year 2024. This represents a 200% increase from $2.11B in 2016.
Ardent Health Partners, LLC (ARDT) grew revenue by 10.3% over the past year. This is steady growth.
Yes, Ardent Health Partners, LLC (ARDT) is profitable, generating $205.1M in net income for fiscal year 2024 (3.5% net margin).
Ardent Health Partners, LLC (ARDT) has a return on equity (ROE) of 16.2%. This is reasonable for most industries.
Ardent Health Partners, LLC (ARDT) generated $154.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.